A citation-based method for searching scientific literature

F Gaba, O Blyuss, D Chandrasekaran, M Osman, S Goyal, C Gan, L Izatt, V Tripathi, I Esteban, L McNicol, K Ragupathy, R Crawford, D G Evans, R Legood, U Menon, R Manchanda. BJOG 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Qualitative Evaluation of Medical Information Processing Needs of 60 Women Choosing Ovarian Cancer Surveillance or Prophylactic Oophorectomy.
Sheri A Babb, Elizabeth M Swisher, Hope N Heller, Alison J Whelan, David G Mutch, Thomas J Herzog, Janet S Rader. J Genet Couns 2002
19
100

Online support groups for women with breast cancer.
Eilis McCaughan, Kader Parahoo, Irene Hueter, Laurel Northouse, Ian Bradbury. Cochrane Database Syst Rev 2017
27
100

Face-to-face vs. online peer support groups for prostate cancer: A cross-sectional comparison study.
Johannes Huber, Tanja Muck, Philipp Maatz, Bastian Keck, Paul Enders, Imad Maatouk, Andreas Ihrig. J Cancer Surviv 2018
34
100

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.
Marline G Harmsen, Marieke Arts-de Jong, Nicoline Hoogerbrugge, Angela H E M Maas, Judith B Prins, Johan Bulten, Steven Teerenstra, Eddy M M Adang, Jurgen M J Piek, Helena C van Doorn,[...]. BMC Cancer 2015
54
100

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.
Amy Finch, Patricia Shaw, Barry Rosen, Joan Murphy, Steven A Narod, Terence J Colgan. Gynecol Oncol 2006
257
100

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
695
100


The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
A C Antoniou, P P D Pharoah, P Smith, D F Easton. Br J Cancer 2004
281
100


Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
100

Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study.
William H Parker, Diane Feskanich, Michael S Broder, Eunice Chang, Donna Shoupe, Cynthia M Farquhar, Jonathan S Berek, JoAnn E Manson. Obstet Gynecol 2013
243
100

Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.
Phuong L Mai, Marion Piedmonte, Paul K Han, Richard P Moser, Joan L Walker, Gustavo Rodriguez, John Boggess, Thomas J Rutherford, Oliver Zivanovic, David E Cohn,[...]. Gynecol Oncol 2017
14
100

Prophylactic oophorectomy in premenopausal women and long-term health.
Lynne T Shuster, Bobbie S Gostout, Brandon R Grossardt, Walter A Rocca. Menopause Int 2008
143
100

Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Joanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, Christian F Singer, Pal Moller, Henry T Lynch, Susan Armel, Beth Karlan, William D Foulkes, Susan L Neuhausen,[...]. J Natl Cancer Inst 2016
121
100

Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: patients' and professionals' perspectives.
Marieke Arts-de Jong, Marline G Harmsen, Nicoline Hoogerbrugge, Leon F Massuger, Rosella P Hermens, Joanne A de Hullu. Gynecol Oncol 2015
23
100


Reflections: The Value of Patient Support Groups.
Amanda Hu. Otolaryngol Head Neck Surg 2017
12
100

Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.
R Manchanda, M Burnell, A Abdelraheim, M Johnson, A Sharma, E Benjamin, C Brunell, E Saridogan, S Gessler, D Oram,[...]. BJOG 2012
37
100


Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.
A Fuchsia Howard, Joan L Bottorff, Lynda G Balneaves, Charmaine Kim-Sing. BMC Womens Health 2010
20
100

Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer.
Ingrid E Fakkert, Elske Marije Abma, Iris G Westrik, Joop D Lefrandt, Bruce H R Wolffenbuttel, Jan C Oosterwijk, Riemer H J A Slart, Eveline van der Veer, Geertruida H de Bock, Marian J E Mourits. Eur J Cancer 2015
24
100

Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma.
Brooke E Howitt, Suchanan Hanamornroongruang, Douglas I Lin, James E Conner, Stephanie Schulte, Neil Horowitz, Christopher P Crum, Emily E Meserve. Am J Surg Pathol 2015
59
100

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Joanna B Madalinska, Judith Hollenstein, Eveline Bleiker, Marc van Beurden, Heiddis B Valdimarsdottir, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2005
164
100

Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube.
Mark A Eckert, Shawn Pan, Kyle M Hernandez, Rachel M Loth, Jorge Andrade, Samuel L Volchenboum, Pieter Faber, Anthony Montag, Ricardo Lastra, Marcus E Peter,[...]. Cancer Discov 2016
94
100

Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.
B A M Heemskerk-Gerritsen, C Seynaeve, C J van Asperen, M G E M Ausems, J M Collée, H C van Doorn, E B Gomez Garcia, C M Kets, F E van Leeuwen, H E J Meijers-Heijboer,[...]. J Natl Cancer Inst 2015
113
100

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D.
Xin Yang, Honglin Song, Goska Leslie, Christoph Engel, Eric Hahnen, Bernd Auber, Judit Horváth, Karin Kast, Dieter Niederacher, Clare Turnbull,[...]. J Natl Cancer Inst 2020
21
100

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.
W A Rocca, J H Bower, D M Maraganore, J E Ahlskog, B R Grossardt, M de Andrade, L J Melton. Neurology 2007
444
100

Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.
Laura L Holman, Sue Friedman, Molly S Daniels, Charlotte C Sun, Karen H Lu. Gynecol Oncol 2014
49
100

Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer.
Ingrid E Fakkert, Eveline van der Veer, Elske Marije Abma, Joop D Lefrandt, Bruce H R Wolffenbuttel, Jan C Oosterwijk, Riemer H J A Slart, Iris G Westrik, Geertruida H de Bock, Marian J E Mourits. PLoS One 2017
6
100

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Jack Cuzick, Ivana Sestak, John F Forbes, Mitch Dowsett, Jill Knox, Simon Cawthorn, Christobel Saunders, Nicola Roche, Robert E Mansel, Gunter von Minckwitz,[...]. Lancet 2014
337
100

Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers.
Joanne Kotsopoulos, Jan Lubinski, Henry T Lynch, Nadine Tung, Susan Armel, Leigha Senter, Christian F Singer, Robert Fruscio, Fergus Couch, Jeffrey N Weitzel,[...]. Breast Cancer Res Treat 2019
3
100

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
Jack Cuzick, John F Forbes, Ivana Sestak, Simon Cawthorn, Hisham Hamed, Kaija Holli, Anthony Howell. J Natl Cancer Inst 2007
354
100

Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis.
N N Basu, S Ingham, J Hodson, F Lalloo, M Bulman, A Howell, D G Evans. Fam Cancer 2015
23
100

A systematic review of women's satisfaction and regret following risk-reducing mastectomy.
Lucy Braude, Laura Kirsten, Jemma Gilchrist, Ilona Juraskova. Patient Educ Couns 2017
10
100

The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Joanna B Madalinska, Marc van Beurden, Eveline M A Bleiker, Heiddis B Valdimarsdottir, Judith Hollenstein, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2006
142
100

Persistence of fimbrial tissue on the ovarian surface after salpingectomy.
Carmen Gan, Rashna Chenoy, Dhivya Chandrasekaran, Elly Brockbank, Antony Hollingworth, Sotiris Vimplis, Alexandra C Lawrence, Arjun R Jeyarajah, David Oram, Nandita Deo,[...]. Am J Obstet Gynecol 2017
15
100


Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M Dunning, James Redman, James Scarth, Inga Plaskocinska,[...]. J Clin Oncol 2020
77
100


An integrative model of shared decision making in medical encounters.
Gregory Makoul, Marla L Clayman. Patient Educ Couns 2006
789
100

Qualitative analysis of how patients decide that they want risk-reducing mastectomy, and the implications for surgeons in responding to emotionally-motivated patient requests.
Stephen L Brown, Demian Whiting, Hannah G Fielden, Pooja Saini, Helen Beesley, Christopher Holcombe, Susan Holcombe, Lyn Greenhalgh, Louise Fairburn, Peter Salmon. PLoS One 2017
9
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.